Cannabinoid Research Shows Promise for HIV TAT Inhibition” – Business Wire

COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to announce the Company has published an article on HIV Haven (www …